Home » Topics » Regulatory » Patents

Patents
RSS

Mitsui's Na+/H+-exchange inhibitors for cardiovascular disorders

Sep. 27, 1996

Bristol-Myers Squibb continues to search for new ET antagonists

Sep. 27, 1996

Quinoline LTD4/LTE4 inhibitors from Ciba-Geigy

Sep. 27, 1996

E. Merck reports PDE IV inhibitors

Sep. 27, 1996

Sagami prepares NGF production-enhancing compounds

Sep. 27, 1996

Natural cerebral function-improving agents from Yamanouchi

Sep. 27, 1996

Neurite outgrowth inducers presented by Kitasato Institute

Sep. 27, 1996

Egis claims new anxiolytics with a favorable side effect profile

Sep. 27, 1996

Novel MAb reported by Kyowa Hakko

Sep. 27, 1996

Lilly's antiobesity proteins

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026